Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
16.97
+0.19 (1.13%)
Aug 21, 2026, 3:45 PM HKT

Qyuns Therapeutics Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,025806.96158.79-9.6621.35
Revenue Growth
26.96%408.18%---54.74%-
Gross Profit
908.13714.4192.19-9.6621.35
Operating Income
559.1330.13-342.28-514.26-324.16-179.34
Net Income
546.1314.45-335.57-507.75-298.19-298.27
Earnings Per Share
2.411.41-1.53-2.47-1.68-2.57
EPS Growth
71.57%-----

Revenue by Geography

Fiscal YearFY 2025FY 2024
Period EndingDec '25 Dec '24
The People's Republic of China (The "PRC")
104.56158.79
The United States
197.8-
Switzerland
504.6-
Total
806.96158.79

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,0161,043556.55377.26614.73620.72
Total Debt
686.51580.01527.6346.06295.25290.26
Net Cash (Debt)
329.19462.628.9631.2319.48330.46
Net Cash Growth
-28.84%1497.61%-7.18%-90.23%-3.32%-
Net Cash Per Share
1.452.070.130.151.802.84

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
519.9399.85-186.09-300.68-225.21-122.58
Capital Expenditures
-7.48-7.48-1.22-7.87-20.11-57.98
Free Cash Flow
512.43392.37-187.31-308.56-245.33-180.55
Free Cash Flow Growth
30.60%-----

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
88.64%88.53%58.06%-100.00%100.00%
Operating Margin
54.57%40.91%-215.55%--3354.95%-840.05%
Pretax Margin
52.40%38.09%-220.26%--3233.09%-1997.96%
Profit Margin
53.30%38.97%-211.33%--3086.22%-1397.13%
FCF Margin
50.02%48.62%-117.96%--2539.08%-845.71%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
6.0912.11----
P/FCF Ratio
6.419.70----
PS Ratio
3.204.729.70---